Product Code: A31354
The global native collagen market size was valued at $305.2 million in 2021, and projected to reach $555.1 million by 2031, with a CAGR of 6.2% from 2022 to 2031.
Collagen has versatile properties that enable it to be extensively used in various industrial applications such as medical, cosmetics, and food & beverages. Hence, increasing application of collagen in the pharmaceutical and cosmetics industry is expected to fuel the demand for collagen products.
Cosmetics application accounted for over 24% of the market share in 2021. Collagen is a structural protein found in animal organisms where it provides for the fundamental structural support. Most commonly it is extracted from mammalian and fish skin. Collagen has attracted significant academic interest as well as the attention of the cosmetic industry due to its interesting properties that include being a natural humectant and moisturizer for the skin. Native collagen-based haircare products help reduce hair thinning and offer protection against sun damage. In addition, it promotes hair growth and boosts scalp hydration. The native collagen market players engage in continuous R&D activities to develop innovative products. They are also increasingly incorporating marine-based native collagen to boost product reach. For instance, COBIOSA produces native marine collagen for hair and skincare applications.
China population is aging faster than almost all countries in modern history. According to census released in 2020 18.7% of China population have people aged 60, and people aged 65 and above accounted for 13.5%. It is estimated that by 2050 the proportion of Chinese over retirement age will become 39% of the total population. In India, according to National Commission of Population report estimated that nearly 138 million elderly people are living in India in 2021. Thus, the growth rate of elderly population is higher than that of the general population. The presence of elderly people in developing countries require nutritional care and health care products increases the demand for native collagen. The gradual rise in awareness among the people living in this region regarding the importance of native collagen to aging people will drive the demand for market. In addition, lack of awareness among the people regarding the native collagen products is hampering the development of the market in this region. Moreover, rapid change in lifestyle and increase in per capita income of the middle class people will also have positive impact on the market.
Changing lifestyles, food habits, adoption of western food habits, an increase in demand for functional ingredients in food products, and an increase in industrial activity leading to the need for process enhancement have contributed to the development of the collagen market in emerging economies. Emerging economies such as the Asia Pacific, South Africa, the Middle East, South America, and Eastern European countries provide excellent opportunities for the growth of the market.
The global native collagen market is segmented on the basis of by source, application and region.
On the basis of source, it is segmented into bovine, porcine, poultry, marine, and others. In addition, on the basis of application, the global Native collagen market is segmented into healthcare and pharmaceuticals, cosmetics, and others. Furthermore, healthcare and pharmaceuticals segment is further bifurcated into bone and joint reconstruction, wound dressing, tissue regeneration, and others.
Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. Presently, North America accounts for the largest share of the market, followed by Asia-Pacific and Europe.
The major companies profiled in this report includes Aviva Systems Biology Corporation, Beyond Biopharma Co., Ltd., Bioiberica S.A.U., Bio-Rad Laboratories, Inc., Cosmo Bio, Creative Enzymes, RayBiotech, Inc., REPROCELL Inc., Rockland Immunochemicals Inc., Symatese, TSI Group Ltd., and Vetoquinol S.A. Additional growth strategies such as expansion of production capacities, acquisition, partnership and research & innovation in the extraction technologies have led to attain key developments in the global native collagen market trends.
Impact of COVID-19 on Global Native Collagen Market
The global COVID-19 pandemic has negative impact on the native collagen market. This market has experienced lower than anticipated demand across all regions compared to pre pandemic levels. The global market has exhibited a decline about 25% in 2020 compared to 2019 due to shutdown of various food processing industries and agricultural activities from where feedstock is used as raw material for the production.
The demand for products with a high nutritive value that offers multiple health benefits increases. Collagen is widely used in supplements targeted toward the aging population. The demand for collagen-based supplements by the aging population is anticipated to increase health, immunity, and overall wellness. Moreover, due to increasing health concerns due to pandemics, consumers now focus on food and beverage product labels. This is projected to provide ample opportunities for pharmaceuticals and healthcare products. The outbreak of pandemic is forecasted to affect the daily operations of collagen manufacturing due to restrictions on transportation and a shortage of laborers. However, the pandemic is anticipated to boost the sales of collagen during the study period, as it attracts attention from health-conscious consumers of different end products in which collagen is used, such as food, beverages, and nutritional products.
Post pandemic crisis, major collagen manufacturers have invested in the development of various products related to native collagen in cosmetics, pharmaceuticals, healthcare, and other sectors. Furthermore, the increase in awareness of the advantages of native collagen for elderly people due to pandemic outbreak have led to increase in the demand which will have positive impact on the market during the forecast period.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the native collagen market analysis from 2021 to 2031 to identify the prevailing native collagen market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the native collagen market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global native collagen market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Source
- Bovine
- Porcine
- Poultry
- Marine
- Others
By Application
- Healthcare and Pharmaceuticals
- End Use
- Bone and Joint Reconstruction
- Wound Dressing
- Tissue Regeneration
- Others
- Cosmetics
- Others
By Region
- North America
- Europe
- Spain
- Rest Of Europe
- Germany
- France
- Italy
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Latin America
- Africa
- Middle East
- Key Market Players
- Creative Enzymes
- Symatese
- Vetoquinol S.A.
- Bio-Rad Laboratories, Inc.
- REPROCELL USA Inc.
- Aviva Systems Biology Corporation
- RayBiotech, Inc.
- Cosmo Bio
- Bioiberica S.A.U
- Rockland Immunochemicals Inc.
- Beyond Biopharma Co., Ltd.
- TSI GROUP
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- 3.7.Pricing Analysis
- 3.8.Value Chain Analysis
- 3.9.Key Regulation Analysis
CHAPTER 4: NATIVE COLLAGEN MARKET, BY SOURCE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Bovine
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Porcine
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Poultry
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Marine
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Others
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
CHAPTER 5: NATIVE COLLAGEN MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Healthcare and Pharmaceuticals
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 5.2.4.1 Bone and Joint Reconstruction Market size and forecast, by region
- 5.2.4.2 Bone and Joint Reconstruction Market size and forecast, by country
- 5.2.4.3 Wound Dressing Market size and forecast, by region
- 5.2.4.4 Wound Dressing Market size and forecast, by country
- 5.2.4.5 Tissue Regeneration Market size and forecast, by region
- 5.2.4.6 Tissue Regeneration Market size and forecast, by country
- 5.2.4.7 Others Market size and forecast, by region
- 5.2.4.8 Others Market size and forecast, by country
- 5.3 Cosmetics
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
CHAPTER 6: NATIVE COLLAGEN MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Source
- 6.2.3 North America Market size and forecast, by Application
- 6.2.3.1 North America Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Source
- 6.2.4.1.2 Market size and forecast, by Application
- 6.2.4.1.2.1 U.S. Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Source
- 6.2.4.2.2 Market size and forecast, by Application
- 6.2.4.2.2.1 Canada Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Source
- 6.2.4.3.2 Market size and forecast, by Application
- 6.2.4.3.2.1 Mexico Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Source
- 6.3.3 Europe Market size and forecast, by Application
- 6.3.3.1 Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Source
- 6.3.4.1.2 Market size and forecast, by Application
- 6.3.4.1.2.1 Germany Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.3.4.2 France
- 6.3.4.2.1 Market size and forecast, by Source
- 6.3.4.2.2 Market size and forecast, by Application
- 6.3.4.2.2.1 France Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.3.4.3 Italy
- 6.3.4.3.1 Market size and forecast, by Source
- 6.3.4.3.2 Market size and forecast, by Application
- 6.3.4.3.2.1 Italy Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.3.4.4 Spain
- 6.3.4.4.1 Market size and forecast, by Source
- 6.3.4.4.2 Market size and forecast, by Application
- 6.3.4.4.2.1 Spain Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.3.4.5 Rest of Europe
- 6.3.4.5.1 Market size and forecast, by Source
- 6.3.4.5.2 Market size and forecast, by Application
- 6.3.4.5.2.1 Rest of Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Source
- 6.4.3 Asia-Pacific Market size and forecast, by Application
- 6.4.3.1 Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 China
- 6.4.4.1.1 Market size and forecast, by Source
- 6.4.4.1.2 Market size and forecast, by Application
- 6.4.4.1.2.1 China Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.4.4.2 Japan
- 6.4.4.2.1 Market size and forecast, by Source
- 6.4.4.2.2 Market size and forecast, by Application
- 6.4.4.2.2.1 Japan Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.4.4.3 India
- 6.4.4.3.1 Market size and forecast, by Source
- 6.4.4.3.2 Market size and forecast, by Application
- 6.4.4.3.2.1 India Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.4.4.4 South Korea
- 6.4.4.4.1 Market size and forecast, by Source
- 6.4.4.4.2 Market size and forecast, by Application
- 6.4.4.4.2.1 South Korea Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.4.4.5 Rest of Asia-Pacific
- 6.4.4.5.1 Market size and forecast, by Source
- 6.4.4.5.2 Market size and forecast, by Application
- 6.4.4.5.2.1 Rest of Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Source
- 6.5.3 LAMEA Market size and forecast, by Application
- 6.5.3.1 LAMEA Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Latin America
- 6.5.4.1.1 Market size and forecast, by Source
- 6.5.4.1.2 Market size and forecast, by Application
- 6.5.4.1.2.1 Latin America Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.5.4.2 Africa
- 6.5.4.2.1 Market size and forecast, by Source
- 6.5.4.2.2 Market size and forecast, by Application
- 6.5.4.2.2.1 Africa Healthcare and Pharmaceuticals Native Collagen Market by End Use
- 6.5.4.3 Middle East
- 6.5.4.3.1 Market size and forecast, by Source
- 6.5.4.3.2 Market size and forecast, by Application
- 6.5.4.3.2.1 Middle East Healthcare and Pharmaceuticals Native Collagen Market by End Use
CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
CHAPTER 8: COMPANY PROFILES
- 8.1 Creative Enzymes
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 Symatese
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 Vetoquinol S.A.
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 Bio-Rad Laboratories, Inc.
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 REPROCELL USA Inc.
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 Aviva Systems Biology Corporation
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 RayBiotech, Inc.
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 Cosmo Bio
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Bioiberica S.A.U
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 Rockland Immunochemicals Inc.
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments
- 8.11 Beyond Biopharma Co., Ltd.
- 8.11.1 Company overview
- 8.11.2 Company snapshot
- 8.11.3 Operating business segments
- 8.11.4 Product portfolio
- 8.11.5 Business performance
- 8.11.6 Key strategic moves and developments
- 8.12 TSI GROUP
- 8.12.1 Company overview
- 8.12.2 Company snapshot
- 8.12.3 Operating business segments
- 8.12.4 Product portfolio
- 8.12.5 Business performance
- 8.12.6 Key strategic moves and developments